Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   

Home > Publications > Research Monographs >    

Buprenorphine: An Alternative Treatment for Opioid Dependence



NIDA Research Monograph, Number 121 [Printed in 1992]

Get Adobe Reader

This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.

Download Monograph121.pdf - Buprenorphine: An Alternative Treatment for Opioid Dependence (1.3 MB)


Introduction-----1
Jack O. Blaine

Buprenorphine-Background to Its Development as a Treatment for Opiate Dependence-----5
John W. Lewis and Donald Walter

Behavioral Pharmacology of Buprenorphine: Issues Relevant to Its Potential in Treating Drug Abuse-----12
James H. Woods, Charles P. France, and Gail D. Winger

Assessment of Buprenorphine in a Drug Discrimination Procedure in Humans-----28
George E. Bigelow and Kenzie L. Preston

Human Laboratory Studies of Buprenorphine-----38
Jack H. Menedelson and Nancy K. Mello

Primate Studies of the Behavioral Pharmacology of Buprenorphine-----61
Nancy K. Mello and Jack H. Mendelson

Phase II Clinical Trials of Buprenorphine: Detoxification and Induction Onto Naltrexone-----101
Thomas R. Kosten, Charles Morgan, and Herbert D. Kleber

Development of Buprenophine for the Treatment of Opioid Dependence-----120
Rolley E. Johnson and Paul J. Fudala

List of NIDA Research Monographs-----142




Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal